{"id":7407,"date":"2021-12-16T07:58:29","date_gmt":"2021-12-16T12:58:29","guid":{"rendered":"https:\/\/puyapeptide.net\/product\/anjiyotensin-ii-angiotensin-ii-human-cas-4474-91-3-kan-basincini-yukseltmek-icin\/"},"modified":"2021-12-16T07:58:29","modified_gmt":"2021-12-16T12:58:29","slug":"anjiyotensin-ii-angiotensin-ii-human-cas-4474-91-3-kan-basincini-yukseltmek-icin","status":"publish","type":"product","link":"https:\/\/puyapeptide.net\/tr\/product\/anjiyotensin-ii-angiotensin-ii-human-cas-4474-91-3-kan-basincini-yukseltmek-icin\/","title":{"rendered":"Anjiyotensin II\/ ANGIOTENSIN II, HUMAN CAS 4474-91-3 Kan bas\u0131nc\u0131n\u0131 y\u00fckseltmek i\u00e7in"},"content":{"rendered":"<h2><strong>Anjiyotensin II\/ ANGIOTENSIN II, HUMAN CAS 4474-91-3 Kan bas\u0131nc\u0131n\u0131 y\u00fckseltmek i\u00e7in<\/strong><\/h2>\n<p>\u00dcr\u00fcn Ad\u0131: ANGIOTENSIN II, HUMAN<br \/>\nSekans\u0131: H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-OH<br \/>\nE\u015f Anlamlar\u0131: DRVYIHPF;[ILE5]-ANGIOTENSIN 2;HYPERTANSION II \u0130NSAN;L-ASP-ARG-VAL-TYR-ILE-HIS-PRO-PHE;H-ASP-ARG-VAL-TYR-ILE-HIS-PRO-PHE-OH;FLORESCEIN-NHCS-NH-ASP-ARG- VAL-TYR-ILE-HIS-PRO-PHE-OH;ASP-ARG-VAL-TYR-ILE-HIS-PRO-PHE-OH 2CH3CHOOH H2O;ANGIOTENSIN II, \u0130NSAN<br \/>\nCAS: 4474-91-3&lt;&amp; &gt;MF: C50H71N13O12<br \/>\nMW: 1046.2<br \/>\nEINECS: 2017-001-1<br \/>\n\u00dcr\u00fcn Kategorileri: Angiotensin;peptid<br \/>\nMol Dosyas\u0131: 4474-91-3.mol<\/p>\n<p>Bu metastatik lenf d\u00fc\u011f\u00fcmlerini i\u00e7eren t\u00fcm\u00f6r dokular\u0131n\u0131n, kan ak\u0131\u015f\u0131 otoreg\u00fclasyonu olmayan ve yan\u0131t veren somatik damarlardan yaln\u0131zca ikincil olarak etkilenen yeni b\u00fcy\u00fcyen damarlardan olu\u015ftu\u011fu bilinmektedir. \u0130nsan anjiyotensin II (AT II). bir vazopress\u00f6r, sistemik kemoterapinin etkinli\u011fini art\u0131rmak i\u00e7in Japonya&#39;da tan\u0131t\u0131ld\u0131. \u00c7e\u015fitli ilerlemi\u015f kanserleri olan hastalarda, taban \u00e7izgisinin 1,5 kat\u0131 (ancak 150 mm Hg&#39;nin \u00fczerinde olmayan) bir ortalama kan bas\u0131nc\u0131 elde etmek i\u00e7in AT II&#39;nin iv inf\u00fczyonu ve ard\u0131ndan geleneksel sitotoksik ajanlar\u0131n bolus enjeksiyonu, t\u00fcm\u00f6r dokular\u0131nda kan ak\u0131\u015f\u0131n\u0131 5-7 kat art\u0131r\u0131r. ve bu nedenle, hedef dokuya ila\u00e7 da\u011f\u0131t\u0131m\u0131n\u0131 artt\u0131r\u0131r ve bu da geli\u015fmi\u015f kemoterap\u00f6tik etkilerle sonu\u00e7lan\u0131r. Bu ind\u00fcklenmi\u015f hipertansiyon kemoterapi rejimi, minimum yan etkilerle g\u00fcvenli bir \u015fekilde uygulanabilir.<\/p>\n<p> <strong>Anjiyotensin II\/ ANGIOTENSIN II, HUMAN CAS 4474-91-3 Kimyasal \u00d6zellikler<\/strong><br \/>\nKaynama noktas\u0131 809.08\u00b0C (kabaca tahmin)&lt;&amp; &gt;yo\u011funluk 1.1257 (kaba tahmin)<br \/>\nk\u0131r\u0131lma indeksi 1.6700 (tahmini)<br \/>\nRTECS BW2165000<br \/>\ndepolama s\u0131cakl\u0131\u011f\u0131. Karanl\u0131k yerde saklay\u0131n,Atmosferde,Dondurucuda -20\u00b0C&#39;nin alt\u0131nda saklay\u0131n<br \/>\nform Toz<br \/>\npka pK1: 10,37 (25\u00b0C)<br \/>\nrenk turuncu<br \/>\nSuda \u00c7\u00f6z\u00fcn\u00fcrl\u00fck Suda \u00c7\u00f6z\u00fcn\u00fcr (25 mg) \/ml) ve %5 Asetik Asit (1 mg\/ml).<br \/>\nInChIKey CZGUSIXMZVURDU-JZXHSEFVSA-N<br \/>\nCAS Veritaban\u0131 Referans\u0131 4474-91-3<\/p>\n<p> <strong>Anjiyotensin II\/ ANGIOTENSIN&#39;in \u0130\u015flevi ve Uygulamas\u0131 II, HUMAN CAS 4474-91-3<\/strong><br \/>\nAngiotensin II, 8 amino asitten olu\u015fan k\u0131sa bir peptittir ve fizyolojik i\u015flevi, esas olarak v\u00fccuttaki k\u00fc\u00e7\u00fck arterleri daraltarak kan bas\u0131nc\u0131n\u0131 y\u00fckseltmektir. Ek olarak, b\u00f6brek t\u00fcb\u00fcllerinde sodyum, su ve potasyumun korunmas\u0131na etki eden ve b\u00f6ylece kan hacminde ve kan bas\u0131nc\u0131nda art\u0131\u015fa neden olan adrenal korteks taraf\u0131ndan aldosteron salg\u0131lanmas\u0131n\u0131 da te\u015fvik edebilir.<\/p>\n<p> <strong>Anjiyotensin Kullan\u0131mlar\u0131 II\/ ANGIOTENSIN II, HUMAN CAS 4474-91-3<\/strong><br \/>\n1. Kardiyopulmoner res\u00fcsitasyon &#8211; hen\u00fcz onaylanm\u0131\u015f bir uygulama de\u011fil<br \/>\n2. Kan bas\u0131nc\u0131n\u0131n d\u00fczenlenmesinde rol oynayan bir peptit<br \/>\n3. Anjiyotensin II, kronik hipertansiyon, kalp yetmezli\u011fi ve fel\u00e7te merkezi rolleri olan bir vazokonstrikt\u00f6r olarak bilinen bir peptit hormonudur. Tipik olarak anjiyotensin d\u00f6n\u00fc\u015ft\u00fcr\u00fcc\u00fc enzim (ACE) taraf\u0131ndan anjiyotensin I&#39;den iki kal\u0131nt\u0131n\u0131n \u00e7\u0131kar\u0131lmas\u0131yla \u00fcretilen bir oktapeptiddir. Anjiyotensin II, her biri farkl\u0131 sinyal yollar\u0131 ve fizyolojik tepkiler uyand\u0131ran AT1 ve AT2 olmak \u00fczere en az iki farkl\u0131 resept\u00f6r i\u00e7in bir ligandd\u0131r. Spesifik anjiyotensin II resept\u00f6r alt tipleri i\u00e7in antagonistlerin geli\u015ftirilmesi, ACE inhibit\u00f6rlerine de\u011ferli bir alternatifi temsil eder.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u00dcr\u00fcn Ad\u0131: ANGIOTENSIN II, HUMAN<br \/>\nCAS: 4474-91-3<br \/>\nMF: C50H71N13O12<br \/>\nMW: 1046.2<br \/>\nEINECS: 2017-001-1<br \/>\nMol Dosyas\u0131: 4474-91-3 .mol<\/p>\n","protected":false},"featured_media":2177,"comment_status":"open","ping_status":"closed","template":"","meta":{"om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"site-sidebar-layout":"default","site-content-layout":"default","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"product_brand":[],"product_cat":[421],"product_tag":[2347,2369],"class_list":{"0":"post-7407","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-kan-ve-vaskuler-peptit","7":"product_tag-angiotensin-ii-angiotensin-ii-tr","8":"product_tag-human-cas-4474-91-3-for-blood-pressure-raising-tr","9":"desktop-align-left","10":"tablet-align-left","11":"mobile-align-left","13":"first","14":"instock","15":"shipping-taxable","16":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/puyapeptide.net\/tr\/wp-json\/wp\/v2\/product\/7407","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/puyapeptide.net\/tr\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/puyapeptide.net\/tr\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/tr\/wp-json\/wp\/v2\/comments?post=7407"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/puyapeptide.net\/tr\/wp-json\/wp\/v2\/media\/2177"}],"wp:attachment":[{"href":"https:\/\/puyapeptide.net\/tr\/wp-json\/wp\/v2\/media?parent=7407"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/puyapeptide.net\/tr\/wp-json\/wp\/v2\/product_brand?post=7407"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/puyapeptide.net\/tr\/wp-json\/wp\/v2\/product_cat?post=7407"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/puyapeptide.net\/tr\/wp-json\/wp\/v2\/product_tag?post=7407"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}